Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› São Paulo
Clinical trial register · Brazil

Clinical Trials in São Paulo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Brazil and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2237 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2237
Studies in scope
all four open statuses
1133
Recruiting now
open to new participants
355
Lead sponsors
across recruiting studies
Top sites
São Paulo 1207 Porto Alegre 897 Rio de Janeiro 471 Curitiba 433 Salvador 348
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca107 University of Sao Paulo General Hospital74 Hoffmann-La Roche62 Merck Sharp & Dohme LLC62 University of Sao Paulo57 Novartis Pharmaceuticals51 Janssen Research & Development, LLC36 Sanofi30 Bristol-Myers Squibb30 GlaxoSmithKline25 University of Nove de Julho23 Eli Lilly and Company23 Pfizer22 AbbVie22 Hospital Israelita Albert Einstein19 Federal University of São Paulo17 Instituto do Cancer do Estado de São Paulo17 Boehringer Ingelheim15 BeOne Medicines13 Novo Nordisk A/S13 Takeda12 Amgen12 Alexion Pharmaceuticals, Inc.11 Regeneron Pharmaceuticals9 Hospital Sirio-Libanes9 Show all 306
Site location
São Paulo1207 Porto Alegre897 Rio de Janeiro471 Curitiba433 Salvador348 Belo Horizonte339 Barretos264 Brasília247 Fortaleza231 Natal216 Campinas200 São José do Rio Preto195 Ribeirão Preto182 Goiânia157 Recife152 Santo André130 Vitória114 Florianópolis109 Ijuí95 Jaú86 Botucatu85 Blumenau73 Joinville69 Passo Fundo63 Belém61 Show all 304
All 304 locations
Target enrolment
to

Trials with a site in São Paulo

1207 of 2237 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Brazil
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Fortaleza, Rio de Janeiro, Porto Alegre, Campinas, Ribeirão Preto, São Paulo
2027-11-23
Not yet open
University of Sao Paulo
Phase 2
106
São Paulo
2027-04-30
Not yet open
University of Sao Paulo General Hospital
Not applicable
300
São Paulo
2027-04
Not yet open
Cardiovascular Pre-participation Screening in Children and Adolescents
NCT07862504Sudden Cardiac Death, Cardiac Arrhythmias
University of Sao Paulo
Observational
334
São Paulo
2027-02
Recruiting
Latin American Cooperative Oncology Group
Observational
350
Salvador, Brasília, Belo Horizonte, Rio de Janeiro, Porto Alegre, São Paulo
2027-02
Not yet open
Eurofarma Laboratorios S.A.
Phase 3
1,252
São Paulo
2027-01-30
Recruiting
A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant Recipients
NCT07898774C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Recurrent Glomerular Disease After Kidney Transplantation
DrugPegcetacoplan
Swedish Orphan Biovitrum
Phase 3
30
Recife, Botucatu, São Paulo
2027-01-21
Not yet open
Boehringer Ingelheim
Phase 3
1,500
Barra Mansa, Botucatu, Brasília, Goiânia, Porto Alegre, São Bernardo do Campo, São Paulo
2027-01-11
Not yet open
CBD Supplementation in Brazilian Jiu-Jitsu Athletes
NCT07552974Pro and Anti Inflamatory Cytokines, Pain, Sleep, Quality of Life
Associação Pan-Americana Multidisciplinar de Endocanabinologia
Phase 2/3
100
São Paulo
2027-01-01
Not yet open
Photobiomodulation in Coronary Artery Bypass Grafting With No-Touch vs Conventional Saphenous Vein Harvesting.
NCT07699679Coronary Artery Disease, Coronary Artery Bypass Graft (CABG), Surgical Wound Healing
Federal University of São Paulo
Not applicable
292
São Paulo
2027-01
Not yet open
Sac-TMT in Vaginal and Vulvar Cancers
NCT07804966Vaginal Squamous Cell Carcinoma, Vulvar Squamous Cell Carcinoma
DrugSacituzumab tirumotecan
Latin American Cooperative Oncology Group
Phase 2
48
Fortaleza, Salvador, São Paulo, Belo Horizonte, João Pessoa, Belém, Teresina, Rio de Janeiro
2027-01
Not yet open
RB-PDT for Fusarium Keratitis: The LUMIERE Study
NCT07743489Fusarium Keratitis
Stanford University
Phase 3
434
São Paulo
2027-01
Not yet open
Fábio Fernandes
Phase 2
20
São Paulo
2027-01
Not yet open
AstraZeneca
Observational
1,500
São Paulo
2026-12-30
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Belo Horizonte, Barra Mansa, Porto Alegre, Blumenau, Botucatu, Santo André, Rio de Janeiro, São Paulo
2026-12-16
Not yet open
Boehringer Ingelheim
Phase 3
270
Juiz de Fora, Porto Alegre - RS, Salvador, São Paulo, Valinhos
2026-12-14
Not yet open
Peer-led Community-based PrEP Delivery Among Youth in Brazil
NCT06661356Pre-Exposure Prophylaxis (PrEP), HIV
University of Alabama at Birmingham
Not applicable
1,400
Salvador, São Paulo
2026-12
Not yet open
Brazilian Clinical Research Institute
Not applicable
336
São Paulo
2026-12
Not yet open
AstraZeneca
Observational
532
Curitiba, Campinas, São Paulo
2026-11-30
Not yet open
Eurofarma Laboratorios S.A.
Phase 3
816
São Paulo
2026-11-30
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Belo Horizonte, Curitiba, Bragança Paulista, Campinas, São Paulo
2026-11-11
Not yet open
Novo Nordisk A/S
Phase 3
1,060
Manaus, Porto Alegre, Campinas, São Paulo
2026-11-10
Not yet open
Novo Nordisk A/S
Phase 3
1,200
Curitiba, Porto Alegre, Campinas, São Paulo
2026-11-10
Not yet open
Novo Nordisk A/S
Phase 3
450
Porto Alegre, Campinas, São Paulo
2026-11-10
Recruiting
Latin American Cooperative Oncology Group
Observational
250
São Paulo
2026-11
Not yet open
Drug-Coated Balloon Only Strategy After Recanalization of Chronic Total Coronary Occlusions
NCT07817719Angina (Stable), Coronary Occlusion, Coronary Artery Disease, Chronic Total Occlusion
University of Sao Paulo General Hospital
Not applicable
38
São Paulo
2026-11
Recruiting
Oncogeriatric Screening and Evaluation Program
NCT07805642Solid Tumor Cancer
Latin American Cooperative Oncology Group
Observational
412
São Paulo
2026-11
Not yet open
University of Sao Paulo
Observational
120
São Paulo
2026-11
Recruiting
Eli Lilly and Company
Phase 3
1,000
Campinas, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
2026-10-16
Recruiting
Novo Nordisk A/S
Phase 3
84
Distrito de Barão Geraldo - Campinas, Ribeirão Preto, São Paulo, Rio de Janeiro
2026-10-16
Recruiting
A Study of DS-3939a in Participants With Solid Tumors
NCT07739966Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
DrugsDS-1103a·DS-3939a·Pemetrexed·Carboplatin
Daiichi Sankyo
Phase 1/2
400
Barretos, Natal, Porto Alegre, Salvador, São Paulo
2026-10-13
Recruiting
Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases
NCT07275580Autoimmune Rheumatic Diseases, Tooth Extraction, Infection Prevention, Antibiotic Prophylaxis
DrugAmoxicillin
University of Sao Paulo General Hospital
Phase 4
352
São Paulo
2026-10-07
Not yet open
Repair Versus Replacement of Failed Restorations in Primary Teeth
NCT07813065Dental Caries, Restoration Defects, Primary Teeth
University of Sao Paulo
Not applicable
382
São Paulo
2026-10-07
Recruiting
Hoffmann-La Roche
Phase 3
400
Belo Horizonte, Porto Alegre, Itajaí, São Paulo
2026-10-06
Not yet open
University of Sao Paulo
Phase 1/2
16
Ribeirão Preto, São Paulo
2026-10-01
Not yet open
Therapeutics for Moderate and Severe Dengue
NCT07543458Dengue, Severe Dengue, Mosquito-Borne Diseases, Vector Borne Diseases
DrugsN-Acetylcysteine·Baricitinib·Dexamethasone
Oxford University Clinical Research Unit, Vietnam
Phase 3
8,800
São Paulo
2026-10-01
Not yet open
Federal University of São Paulo
Not applicable
90
São Paulo
2026-10-01
Not yet open
Patient Characterization Panel to Improve Satisfaction With the Intensive Care Unit Stay (CONNECT)
NCT07830043Critical Illness, Family Satisfaction, Critical Care, Intensive Care
University of Sao Paulo General Hospital
Not applicable
966
Fortaleza, São Paulo
2026-10
Not yet open
Farmoquimica S.A.
Not applicable
48
São Paulo
2026-10
Recruiting
AstraZeneca
Phase 3
750
Salvador, São Paulo
2026-09-24
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Porto Alegre, São Caetano do Sul, São José do Rio Preto, São José dos Campos, São Paulo, Teresina, Vitória
2026-09-24
Recruiting
Boehringer Ingelheim
Phase 3
466
Goiânia, Porto Alegre, Recife, São José do Rio Preto, São Paulo
2026-09-17
Recruiting
AstraZeneca
Phase 3
950
Fortaleza, Itajaí, Jaú, Natal, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
2026-09-16
Recruiting
AstraZeneca
Phase 3
1,330
Barretos, Brasília, Natal, Porto Alegre, São Caetano do Sul, São Paulo
2026-09-15
Recruiting
Science Valley Research Institute
Observational
1,592
São Paulo
2026-09-11
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Vitória, Goiânia, Ijuí, Pelotas, Bauru, Jaú, São Paulo
2026-09-11
Recruiting
Takeda
Phase 3
324
Rio de Janeiro, Porto Alegre, Florianópolis, Joinville, Jaú, São Paulo
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 2
160
Natal/RN, Porto Alegre, Barretos, São Paulo
2026-09-10
Recruiting
Fundación Huésped
Phase 4
210
Salvador, Curitiba, Nova Iguaçu, Natal, São Paulo
2026-09-10
Recruiting
Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression
NCT07925762Postpartum Depression, Depression, Postpartum
University of Sao Paulo
Not applicable
104
São Paulo
2026-09-09
Recruiting
Biocon Biologics UK PLC
Phase 1
120
Bento Gonçalves, Ijuí, Pará, Porto Alegre, Rio de Janeiro, Santa Catarina, São Paulo
2026-09-09
Recruiting
Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients
NCT07771400Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Fallopian Tube Cancer Stage III
Latin American Cooperative Oncology Group
Observational
320
Belo Horizonte, Campo Grande, Recife, Rio de Janeiro, Natal, Porto Alegre, Lages, São Paulo
2026-09-08
Not yet open
IBIS - Investigating Reliability of BIS and SEDLINE Monitoring in Children With Developmental and Epileptic Encephalopathies (DEE).
NCT07585643Epileptic Encephalopathy, Early Infantile Epileptic Encephalopathy, Infantile Spasm, Developmental and Epileptic Encephalopathies
Telethon Kids Institute
Observational
40
São Paulo
2026-09-03
Recruiting
Associação de Assistência a Criança Deficiente
Not applicable
42
São Paulo
2026-09-02
Recruiting
University of Nove de Julho
Not applicable
80
São Paulo
2026-09-01
Recruiting
Virtual Reality in Intensive Care Unit: Patient Satisfaction, Clinical and Functional Outcomes, Feasibility
NCT07089134Hospitalized Patients, ICU Hospitalization, Intensive Care Unit-acquired Weakness
Hospital Sirio-Libanes
Not applicable
90
São Paulo
2026-09-01
Not yet open
Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women
NCT07783295Chronic Pain, Fibromyalgia, Osteoporosis, Orofacial Pain
Associação Pan-Americana Multidisciplinar de Endocanabinologia
Phase 2
80
São Paulo
2026-09-01
Not yet open
Efficacy of Oral Hygiene Regimens in Patients Undergoing Non-Surgical Periodontal Treatment
NCT07803484Periodontal Disease, Gingival Inflammation and Bleeding
Colgate Palmolive
Phase 3
100
Porto Alegre, São Paulo
2026-09-01
Recruiting
Safety of CRT100 on Treatment Spinal Cord Injury
NCT05739734Thoracic Spinal Cord Injury
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase 1
5
São Paulo
2026-09
Recruiting
AstraZeneca
Phase 3
1,072
Belo Horizonte, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
2026-08-31
Recruiting
The Use of Photobiomodulation in the Treatment of Spasticity After Stroke.
NCT07784231Stroke, Spasticity, Photobiomodulation, NIRS
University of Nove de Julho
Phase 1/2
42
São Paulo
2026-08-28
Recruiting
InCor Heart Institute
Not applicable
80
São Paulo
2026-08-24
Recruiting
AstraZeneca
Phase 3
500
Belo Horizonte, Campinas, São Paulo
2026-08-24
Not yet open
Enhancing Patient Experience in Geriatric Oncology
NCT07671586Confort, Older Adults With Cancer
Hospital Sirio-Libanes
Not applicable
264
São Paulo
2026-08-20
Recruiting
Hoffmann-La Roche
Phase 3
100
Porto Alegre, Jaú, São Paulo
2026-08-18
Not yet open
Sleep Quality - Comparing the Effect of Ondansetron or Dexamethasone Given as Routine Prophylaxis Intraoperatively to Prevent Post Operative Nausea and Vomiting (SCORPION)
NCT07777276Postoperative Sleep Quality, Postoperative Behaviour, Postoperative Recovery in Children, Postoperative Nausea and Vomiting (PONV)
DrugsOndansetron·Dexamethasone
Telethon Kids Institute
Phase 4
500
São Paulo
2026-08-17
Recruiting
Eli Lilly and Company
Phase 3
1,000
Campinas, Curitiba, Joinville, Passo Fundo, Recife, São Bernardo do Campo, São José do Rio Preto, São Paulo
2026-08-14
Recruiting
University of Sao Paulo
Not applicable
1,000
São Paulo
2026-08-08
Recruiting
Novo Nordisk A/S
Phase 3
80
Bairro Rodolfo Teófilo, Fortaleza, Curitiba, Porto Alegre, Ribeirão Preto, São Paulo
2026-08-04
Not yet open
Hospital Sirio-Libanes
Not applicable
264
São Paulo
2026-08-01
Not yet open
Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial
NCT07039539Drug Abuse, Harm Reduction, Minimization, Harm, Anabolic Steroids Adverse Events
University of Sao Paulo
Not applicable
32
São Paulo
2026-08-01
Recruiting
Inhaled DMT for Major Depressive Disorder
NCT07562191MDD, Major Depressive Disorder (MDD), Major Depression, Suicidal Ideation
DrugN,N-Dimethyltryptamine
Universidade Federal do Rio Grande do Norte
Phase 2
140
Fortaleza, Salvador, Rio de Janeiro, Natal, São Paulo
2026-08-01
Recruiting
Federal University of São Paulo
Phase 2
70
São Paulo
2026-08-01
Not yet open
D'Or Institute for Research and Education
Phase 3
227
São Paulo
2026-08-01
Not yet open
Incidence of Tuberculosis in Patients With Autoimmune Rheumatic Diseases
NCT07731672Autoimmune Rheumatic Diseases, Prevention
University of Sao Paulo General Hospital
Not applicable
1,660
São Paulo
2026-08-01
Recruiting
VectivBio AG
Phase 3
124
Teresina, Caxias do Sul, Porto Alegre, São José do Rio Preto, São Paulo
2026-08
Not yet open
Magnetic Ressonance Imaging of Temporomandibular Joint
NCT02294799Temporomandibular Joint Dysfunction
Daniela Ap. Biasotto-Gonzalez
Not applicable
24
São Paulo
2026-08
Recruiting
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
NCT06419205IgA Nephropathy, Lupus Nephritis (LN), C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics
Phase 2
30
São Paulo
2026-07-30
Not yet open
University of Nove de Julho
Not applicable
60
São Paulo
2026-07-30
Recruiting
Boehringer Ingelheim
Phase 3
448
Curitiba, Porto Alegre, Recife, Salvador, São Paulo, Valinhos
2026-07-27
Recruiting
University of Sao Paulo General Hospital
Phase 4
196
São Paulo
2026-07-22
Recruiting
Boehringer Ingelheim
Phase 3
35
Barra Mansa, Porto Alegre, Recife, São Paulo
2026-07-21
Recruiting
Amgen
Phase 2
15
Salvador, São Paulo
2026-07-21
Recruiting
AstraZeneca
Phase 3
915
Barretos, Curitiba, Salvador, São Paulo
2026-07-16
Recruiting
Novartis Pharmaceuticals
Phase 3
570
São Paulo
2026-07-16
Recruiting
Federal University of São Paulo
Phase 2
70
São Paulo
2026-07-15
Recruiting
University of Sao Paulo General Hospital
Not applicable
50
São Paulo
2026-07-10
Recruiting
Boehringer Ingelheim
Phase 3
390
Barretos, Recife, São José do Rio Preto, São Paulo
2026-07-10
Recruiting
Eli Lilly and Company
Phase 3
170
Campinas, Goiânia, Passo Fundo, Porto Alegre, São Paulo
2026-07-08
Recruiting
University of Sao Paulo
Observational
90
São Paulo
2026-07-08
Recruiting
AstraZeneca
Phase 3
1,200
Brasília, Campinas, Curitiba, Natal, Porto Alegre, São José dos Campos, São Paulo
2026-07-06
Recruiting
AbbVie
Phase 3
531
São Paulo
2026-07-02
Recruiting
AbbVie
Observational
1,000
São Paulo
2026-07-02
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
DrugPF-08634404
Pfizer
Phase 2
40
São Paulo, Porto Alegre
2026-07-02
Recruiting
University of Sao Paulo
Phase 2
40
São Paulo
2026-07-01
Recruiting
AstraZeneca
Phase 3
4,500
Belém, Brasília, Campinas, Curitiba, Fortaleza, Porto Alegre, São José dos Campos, São Paulo
2026-06-29
Recruiting
ITB-Med LLC
Phase 2
120
Belo Horizonte, Porto Alegre, São José do Rio Preto, São Paulo
2026-06-29
Recruiting
AstraZeneca
Phase 3
750
Salvador, São Paulo
2026-06-26
Recruiting
ViiV Healthcare
Phase 3
564
Curitiba, Nova Iguaçu, Rio de Janeiro, Salvador, São Paulo
2026-06-25
Recruiting
Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases
NCT07341386Autoimmune Rheumatic Diseases, Recurrent Herpes Simplex, Prevention
DrugAcyclovir
University of Sao Paulo General Hospital
Phase 4
62
São Paulo
2026-06-25
Recruiting
Hoffmann-La Roche
Phase 3
380
São Paulo, Rio de Janeiro
2026-06-23
Recruiting
University of Sao Paulo General Hospital
Phase 4
192
São Paulo
2026-06-22
Active, closed
Instituto do Cancer do Estado de São Paulo
Not applicable
40
São Paulo
2026-06-19
Recruiting
Instituto do Cancer do Estado de São Paulo
Phase 1
18
São Paulo
2026-06-16
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 3
132
São Paulo
2026-06-12
Recruiting
Regeneron Pharmaceuticals
Phase 3
35
Ribeirão Preto, Santo André, São Paulo
2026-06-11
Recruiting
Pfizer
Phase 3
954
Brasília, Campinas, São José do Rio Preto, São Paulo
2026-06-10
Recruiting
Instituto do Cancer do Estado de São Paulo
Not applicable
583
São Paulo
2026-06-09
Recruiting
AstraZeneca
Phase 2
80
Goiânia, Porto Alegre, São Paulo
2026-06-04
Recruiting
GlaxoSmithKline
Phase 3
600
São Luís, CuritibaPR, Porto Alegre, São Paulo, Vitória
2026-06-04
Recruiting
Bayer
Phase 3
117
Salvador, Uberlândia, Curitiba, Porto Alegre, Marília, São Paulo
2026-06-01
Not yet open
Instituto do Cancer do Estado de São Paulo
Not applicable
100
São Paulo
2026-06
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Brasília, Curitiba, Florianópolis, Joinville, Porto Alegre, Rio de Janeiro, São José do Rio Preto, São Paulo
2026-05-31
Not yet open
Effects of Physical Training in Patients With Advanced Heart Failure
NCT07501143Insuficiência Cardíaca, Transplante Cardíaco, Exercício Físico
University of Nove de Julho
Not applicable
22
São Paulo
2026-05-30
Recruiting
Archo Medical S.A
Not applicable
10
Florianópolis, São Paulo
2026-05-26
Recruiting
Hoffmann-La Roche
Phase 2
30
Salvador, Brasília, Cuiab, Niterói, Porto Alegre, Ribeiro Preto, São Paulo
2026-05-25
Recruiting
Takeda
Phase 3
300
Salvador, Porto Alegre, Joinville, Jaú, Santos, São Paulo
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Vitória, Brasília, Recife, Porto Alegre, São Carlos, São Paulo
2026-05-21
Active, closed
Novo Nordisk A/S
Phase 3
985
Porto Alegre, Campinas, São Paulo
2026-05-20
Recruiting
Takeda
Phase 2
222
Porto Alegre, Botucatu, Campinas, Ribeirão Preto, São José do Rio Preto, São Paulo
2026-05-17
Recruiting
Social Deprivation and Postoperative Mortality
NCT07621211Social Deprivation
Hospital de Clinicas de Porto Alegre
Observational
45,000
Salvador, São Luís, Curitiba, Criciuma, Porto Alegre, São Paulo
2026-05-15
Recruiting
Multicenter Study for External Validation of the TB-NET Score
NCT07903532Tumor Burden, Neuroendocrine (NE) Tumors
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Observational
400
São Paulo
2026-05-12
Recruiting
Beneficência Portuguesa de São Paulo
Observational
1,000
Fortaleza, Recife, Florianópolis, Marília, São José do Rio Preto, São Paulo
2026-05-11
Not yet open
Hypothermic Machine Perfusion for Liver Graft Preservation
NCT07595627Liver Transplant, Liver Failure
University of Sao Paulo General Hospital
Not applicable
40
São Paulo
2026-05-07
Recruiting
Mirati Therapeutics Inc.
Phase 2
170
São Paulo
2026-05-06
Recruiting
AstraZeneca
Observational
2,150
Fortaleza, Curitiba, Natal, Porto Alegre, Campinas, São José dos Campos, São Paulo, Barretos
2026-05-06
Recruiting
University of California, San Francisco
Phase 2
30
São Paulo
2026-05-05
Recruiting
Eli Lilly and Company
Phase 2
60
Campinas, Caxias do Sul, Curitiba, Marília, São Paulo, Vitória
2026-05-04
Recruiting
AstraZeneca
Phase 3
670
São Paulo
2026-05-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
Pasos Fundo, São Paulo
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Campinas, Caxias do Sul, Curitiba, Marília, São Paulo, Vitória
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Curitiba, São Paulo
2026-05-03
Recruiting
St. Jude Children's Research Hospital
Phase 2
52
Barretos, São Paulo
2026-05-01
Not yet open
Prospective Registry of Vertigo Due to Vertebrobasilar Transient Attacks.
NCT07421973Vertigo, Dizziness, TIA (Transient Ischemic Attack), Transient Neurologic Symptoms
University of Sao Paulo General Hospital
Observational
400
São Paulo
2026-05-01
Recruiting
University of Sao Paulo
Not applicable
34
São Paulo
2026-05-01
Recruiting
Mechanochemical Ablation Versus Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein
NCT07561320Varicose Veins of Leg With Long Saphenous Vein Distribution, Varicose Veins of Lower Limb
DrugPolidocanol foam sclerotherapy
Antonio Eduardo Zerati
Phase 4
50
São Paulo
2026-05
Not yet open
AstraZeneca
Observational
100
São Paulo
2026-04-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
140
Porto Alegre, Barretos, São José do Rio Preto, São Paulo
2026-04-30
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Salvador, São Bernardo do Campo, São Paulo
2026-04-30
Recruiting
SBRT-LATTICE-PATHY
NCT07645261Cancer (Advanced Stage), Cancer (Solid Tumors), Tumor
University of Sao Paulo General Hospital
Phase 2
20
São Paulo
2026-04-28
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
NCT07354074Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
DrugsAsciminib single agent·ABL001
Novartis Pharmaceuticals
Phase 2
50
Rio de Janeiro, Barretos, São Paulo
2026-04-28
Recruiting
Biogen
Phase 3
30
Porto Alegre, Distrito Federal, Sai Paula, São Paulo
2026-04-28
Recruiting
Hoffmann-La Roche
Phase 3
360
Ribeirão Preto, São Paulo
2026-04-27
Recruiting
ReValve Solutions Inc.
Early Phase 1
25
São Paulo
2026-04-26
Recruiting
AstraZeneca
Observational
350
São Paulo
2026-04-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
2026-04-23
Recruiting
Boehringer Ingelheim
Phase 2
405
Curitiba, Juiz de Fora, Porto Alegre, Salvador, São José do Rio Preto, São Paulo, Valinhos
2026-04-20
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Belo Horizonte, Curitiba, Goiânia, Porto Alegre, Rio de Janeiro, São José do Rio Preto, São Paulo
2026-04-17
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
NCT07496567Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration
DrugsTiespectus·Eylea·Aflibercept
EyeBiotech Ltd.
Phase 2/3
960
São Paulo
2026-04-15
Recruiting
Hoffmann-La Roche
Phase 3
100
Porto Alegre, Jaú, São Paulo
2026-04-15
Active, closed
Novo Nordisk A/S
Phase 3
638
Curitiba, Campinas, São Paulo
2026-04-13
Recruiting
Hoffmann-La Roche
Phase 2
80
Vitória, Brasília, Curitiba, São Paulo
2026-04-07
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Brasília, Campinas, São Paulo
2026-04-01
Recruiting
Chiesi Farmaceutica Ltda.
Observational
396
São Paulo
2026-04-01
Active, closed
University of Sao Paulo
Not applicable
1
São Paulo
2026-04-01
Recruiting
University of Sao Paulo
Not applicable
88
São Paulo
2026-04
Recruiting
AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation
NCT07438327Aortic Aneurysm, Aortic Aneurysm Abdominal, Aortic Aneurysm and Dissection, Aortic Aneurysm, Thoracoabdominal
Aiatella Oy
Observational
250
São Paulo
2026-03-31
Recruiting
InRAD Observational Study
NCT07213700Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), Non-Alzheimer Degenerative Dementia
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Observational
50,000
São Paulo
2026-03-30
Recruiting
Acute Treatment and Long-term Assessment of Adult Infectious Meningitis
NCT07027475Viral Meningitis, Bacterial Meningitis, Fungal Meningitis, Meningitis
Hospital Israelita Albert Einstein
Observational
624
Fortaleza, Passo Fundo, Porto Alegre, Ribeirão Preto, São Paulo
2026-03-30
By invitation
University of Nove de Julho
Not applicable
72
São Paulo
2026-03-30
Recruiting
Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis
NCT07062445Meningitis, Bacterial Infections, Viral Meningitis, Fungal Meningitis
Hospital Israelita Albert Einstein
Observational
600
São Paulo
2026-03-29
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Campinas, Caxias do Sul, Curitiba, Fortaleza, Porto Alegre, Salvador, Santos, São Paulo
2026-03-26
Recruiting
Screening for Dysglycemia During Postpartum Period in Women With GDM
NCT07489456Gestational Diabetes Mellitus (GDM)
University of Sao Paulo General Hospital
Not applicable
182
São Paulo
2026-03-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
450
São Paulo
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 2
132
Fortaleza, Porto Alegre, São Paulo
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Goiânia, Porto Alegre, Aracaju, São José do Rio Preto, São Paulo, Rio de Janeiro
2026-03-23
Recruiting
Hospital Israelita Albert Einstein
Not applicable
60
São Paulo
2026-03-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Fortaleza, Vitória, Belo Horizonte, Recife, Porto Alegree, Santo André, Taubaté, São Paulo
2026-03-18
Recruiting
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
NCT07087912Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), Systemic Lupus Erythematosus (SLE), Juvenile Systemic Lupus Erythematosus
DrugButantan-DV
University of Sao Paulo General Hospital
Phase 4
477
São Paulo
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Goiânia, Natal, Porto Alegre, São José do Rio Preto, São Paulo
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
850
Teresina, Natal, Porto Alegre, Barretos, São José do Rio Preto, São Paulo
2026-03-16
Recruiting
Sanofi
Phase 2/3
526
Fortaleza, Porto Alegre, São Paulo
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
750
Fortaleza, Natal, Porto Alegre, Barretos, São Paulo, Taubaté
2026-03-12
Recruiting
Hoffmann-La Roche
Phase 2
100
Porto Alegre, Santo André, São José do Rio Preto, Rio de Janeiro, São Paulo
2026-03-11
Recruiting
Hoffmann-La Roche
Phase 2
360
São Paulo
2026-03-10
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
DrugsCetuximab·Nab-paclitaxel·Gemcitabine
Revolution Medicines, Inc.
Phase 3
900
Florianópolis, São Paulo
2026-03-09
Not yet open
Empagliflozin Adjunctive Therapy in Bipolar Depression
NCT07472920Bipolar Disorder, Bipolar Depression, Insulin Resistance
DrugDapagliflozin
University of Sao Paulo
Not applicable
20
São Paulo
2026-03-09
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Goiânia, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, São José do Rio Preto, São Paulo, Vitória
2026-03-05
Recruiting
University of Sao Paulo
Observational
45
São Paulo
2026-03-05
Recruiting
Effect of Meditation as an Adjunct to Cardiac Rehabilitation
NCT07310992High Blood Pressure (& [Essential Hypertension]), Meditation Training, Rehabilitation Exercise
Instituto Dante Pazzanese de Cardiologia
Not applicable
80
São Paulo
2026-03-03
Active, closed
Fabio Biscegli Jatene
Not applicable
3,000
São Paulo
2026-03-02
Active, closed
University of Sao Paulo
Not applicable
70
São Paulo
2026-03-02
Recruiting
Dynamic and Isometric Strength Training in Older Adults With Hypertension
NCT07448818Hypertension, Elderly (People Aged 65 or More)
Raphael Mendes Ritti Dias
Not applicable
60
São Paulo
2026-03-01
Recruiting
Uppsala University
Observational
2,000
São Paulo
2026-03-01
Not yet open
Caio Júlio César dos Santos Fernandes
Observational
30
São Paulo
2026-03-01
Recruiting
Pediatric Airway: Noninferiority Trial of Devices for Intubation Assessment
NCT07351227Intubation, Intratracheal, Airway Management, Video Laryngoscope, Cost Effectiveness
University of Sao Paulo General Hospital
Not applicable
226
São Paulo
2026-03-01
Recruiting
Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
NCT07262320Dialysis, Critically Ill Acute Kidney Injury, Renal Replacement Therapy for Acute Kidney Injury in ICU, Acute Kidney Injury
University of Alabama at Birmingham
Observational
1,000
Bahia, Porto Alegre, São Paulo
2026-03-01
Recruiting
Lifestyle Intervention for Obesity and Eating Disorder Prevention in Transgender Adolescents
NCT07466069Obesity & Overweight, Eating Disorders, Body Image Disturbance, Gender Diverse Populations
University of Sao Paulo
Not applicable
24
São Paulo
2026-03
Recruiting
Raphael Mendes Ritti Dias
Not applicable
40
São Paulo
2026-02-28
Recruiting
TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
NCT07153276Sjogren Syndrome, Sjogren Disease, Primary Sjogren Syndrome
University of Sao Paulo General Hospital
Phase 4
60
São Paulo
2026-02-27
Recruiting
AstraZeneca
Phase 3
508
Salvador, São Paulo
2026-02-23
Recruiting
University of Nove de Julho
Not applicable
90
São Paulo
2026-02-20
Recruiting
University of Sao Paulo General Hospital
Phase 4
263
São Paulo
2026-02-19
Recruiting
TRIS: Contingency Management App for Alcohol Use Disorder
NCT07735585Alcohol Use Disorder (AUD)
University of Sao Paulo General Hospital
Not applicable
130
São Paulo
2026-02-19
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
614
São Paulo
2026-02-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Salvador, Natal, Porto Alegre, Lages, São José do Rio Preto, Rio de Janeiro, São Paulo
2026-02-16
Recruiting
Boehringer Ingelheim
Phase 3
286
Campinas, Fortaleza, Porto Alegre, Recife, São Paulo
2026-02-16
Recruiting
GlaxoSmithKline
Phase 1
44
Campinas, São Paulo
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
900
Curitiba, Fortaleza, São Paulo, Vitória, Votuporanga
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
800
Campinas, Marília, Porto Alegre, Recife, Rio de Janeiro, Santo André, São Paulo
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
1,000
Belo Horizonte, Curitiba, Maringá, Marília, Natal, Rio de Janeiro, São Bernardo do Campo, São Paulo
2026-02-09
Active, closed
EyePoint Pharmaceuticals, Inc.
Phase 3
240
Aracaju, Blumenau, São Paulo
2026-02-09
Recruiting
BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia
NCT07204990Endotracheal Extubation, Airway Anesthesia, Paediatric
Telethon Kids Institute
Not applicable
1,400
São Paulo
2026-02-06
Recruiting
Eli Lilly and Company
Phase 3
1,980
Brasília, Campinas, Fortaleza, Marília, Porto Alegre, Rio de Janeiro, São Paulo
2026-02-06
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Campinas, Caxias do Sul, Curitiba, Florianópolis, Rio de Janeiro, Salvador, São José do Rio Preto, São Paulo
2026-02-04
Recruiting
Alnylam Pharmaceuticals
Phase 3
125
Ribeirão Preto, Rio de Janeiro, Salvador, São Paulo
2026-02-03
Recruiting
ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention
NCT07497594Contact With or Exposure to Human Immunodeficiency Virus
DrugLenacapavir long-acting
Oswaldo Cruz Foundation
Not applicable
1,500
Manaus, Salvador, Nova Iguaçu, Rio de Janeiro, Florianópolis, Campinas, São Paulo
2026-02-03
Recruiting
AstraZeneca
Phase 3
2,130
Barretos, Fortaleza, Natal, Porto Alegre, Salvador, Santa Maria, São Paulo, Vitória
2026-02-03
Active, closed
University of Sao Paulo General Hospital
Not applicable
82
São Paulo
2026-02-02
Recruiting
University of Nove de Julho
Not applicable
60
São Paulo
2026-01-30
Recruiting
Virdx, Inc.
Observational
300
São Paulo
2026-01-28
Recruiting
University of Sao Paulo General Hospital
Phase 4
36
São Paulo
2026-01-28
Recruiting
Hospital Israelita Albert Einstein
Observational
30
São Paulo
2026-01-26
Recruiting
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
NCT07159841Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 2/3
153
Porto Alegre, Ribeirão Preto, São Paulo
2026-01-22
Recruiting
BeOne Medicines
Phase 3
500
Brasília, Porto Alegre, Salvador, São Paulo
2026-01-22
Active, closed
Janssen Research & Development, LLC
Phase 2
189
Curitiba, Porto Alegre, Rio de Janeiro, Santo André, São Paulo
2026-01-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Goiânia, Natal, Porto Alegre, Barretos, São José do Rio Preto, São Paulo, Rio de Janeiro
2026-01-19
Recruiting
Boehringer Ingelheim
Phase 3
400
Barretos, Maceió, Natal, Porto Alegre, Santo André, São Paulo
2026-01-16
Recruiting
University of Sao Paulo General Hospital
Phase 4
114
São Paulo
2026-01-16
Recruiting
São Paulo State University
Phase 1/2
36
São Paulo
2026-01-15
Recruiting
Takeda
Phase 3
183
Joinville, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
2026-01-14
Recruiting
Servier Bio-Innovation LLC
Phase 1
30
São José do Rio Preto, São Paulo
2026-01-14
Recruiting
Eli Lilly and Company
Phase 3
150
Belo Horizonte, Curitiba, Fortaleza, Goiânia, Marília, Rio de Janeiro, São Paulo
2026-01-12
Recruiting
University of Sao Paulo
Phase 3
40
São Paulo
2026-01-09
Recruiting
Javelin Medical
Not applicable
2,000
Curitiba, Monte Alegre, Porto Alegre, Salvador, São José do Rio Preto, São Paulo, Vitória
2026-01-09
Recruiting
Janssen Research & Development, LLC
Phase 3
258
Criciúma, Natal, Salvador, São Bernardo do Campo, São Paulo
2026-01-08
Recruiting
Telethon Kids Institute
Not applicable
500
São Paulo
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Belo Horizonte, Porto Alegre, Blumenau, Ribeirão Preto, São Paulo
2026-01-07
Recruiting
Skyhawk Therapeutics, Inc.
Phase 2/3
400
Belo Horizonte, Campina Grande do Sul, Curitiba, Rio de Janeiro, Natal, Ribeirão Preto, São Paulo
2026-01-06
Recruiting
Biogen
Phase 2
81
Vila São José, São Paulo
2026-01-05
Recruiting
Regeneron Pharmaceuticals
Phase 3
915
Belo Horizonte, Curitiba, Niterói, Porto Alegre, Joinville, Lages, Ribeirão Preto, São Paulo
2026-01-02
By invitation
Libbs Farmacêutica LTDA
Observational
1,342
São Paulo
2026-01
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Curitiba, Natal, Porto Alegre, Santa Cruz do Sul, Barretos, São José do Rio Preto, São Paulo
2025-12-31
Recruiting
Sanofi
Phase 2
144
Salvador, Campinas, São Paulo
2025-12-29
Active, closed
Amgen
Phase 3
250
Porto Alegre, Campinas, São Paulo
2025-12-19
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Bauru, Natal, Santa Cruz do Sul, Santo André, São Paulo
2025-12-19
Recruiting
Sanofi
Phase 3
85
Campinas, Ribeirão Preto, São Paulo
2025-12-18
Recruiting
Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
NCT06343870Menopause, Testosterone Deficiency, Estrogen Deficiency
University of Sao Paulo General Hospital
Phase 3
140
São Paulo
2025-12-18
Recruiting
Ottimo Pharma Limited
Phase 1/2
170
Ijuí, Porto Alegre, São Paulo
2025-12-17
Recruiting
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
NCT07194070Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC
Observational
175
Campinas, São Paulo
2025-12-17
Not yet open
Non-invasive Intracranial Pressure Monitoring to Improve Emergency Care in Brazil's Public Health System
NCT07210333Traumatic Brain Injury (TBI) Patients, Stroke Hemorrhagic, Stroke Ischemic
Braincare USA Corp
Observational
300
Manaus, Lagarto, São Paulo
2025-12-16
Recruiting
AstraZeneca
Phase 2
320
Juiz de Fora, Pelotas, Porto Alegre, Salvador, São Paulo
2025-12-15
Recruiting
Pfizer
Phase 3
800
Recife, Porto Alegre, São Caetano do Sul, Rio de Janeiro, São Paulo
2025-12-11
Recruiting
University of Nove de Julho
Not applicable
60
São Paulo
2025-12-10
Recruiting
Hospital Sirio-Libanes
Not applicable
158
São Paulo
2025-12-08
Recruiting
AstraZeneca
Phase 3
1,100
Barretos, Natal, Porto Alegre, Ribeirão Preto, São Paulo, Vitória
2025-12-04
Recruiting
Bristol-Myers Squibb
Phase 3
366
Salvador, Curitiba, Porto Alegre, Campinas, Ribeirão Preto, São Paulo
2025-12-03
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Jaú, Natal, Porto Alegre, São José do Rio Preto, São Paulo, Vitória
2025-12-03
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
NCT07201558Rheumatoid Arthritis, Systemic Lupus Erythematosus
DrugSurovatamig
AstraZeneca
Phase 1
48
Porto Alegre, Salvador, São Paulo
2025-12-02
Recruiting
University of Sao Paulo General Hospital
Phase 4
200
São Paulo
2025-12-02
Recruiting
Bristol-Myers Squibb
Phase 3
650
Brasília, Curitiba, Porto Alegre, Campinas, Rio de Janeiro, São Paulo
2025-12-02
Not yet open
Hospital Israelita Albert Einstein
Phase 2
42
São Paulo
2025-12
Recruiting
Genmab
Phase 3
660
Rio de Janeiro, Porto Alegre, São Paulo
2025-11-28
Recruiting
Debiopharm International SA
Phase 3
119
Brasília, Curitiba, Fortaleza, Minas Gerais, Rio de Janeiro, São Paulo
2025-11-26
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 2
78
Barretos, Belo Horizonte, Porto Alegre, São Paulo
2025-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Cuiabá, Natal, Porto Alegre, São José do Rio Preto, São Paulo
2025-11-26
Recruiting
Syndax Pharmaceuticals
Phase 3
468
São Paulo, Fortaleza, Barretos, Jaú, Porto Alegre
2025-11-25
Active, closed
Amgen
Phase 3
250
Porto Alegre, Campinas, São Paulo
2025-11-25
Recruiting
AstraZeneca
Observational
200
Recife, Rio de Janeiro, Salvador, São Paulo
2025-11-25
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Barretos, Fortaleza, Natal, Pelotas, Porto Alegre, São Paulo
2025-11-24
Recruiting
Hoffmann-La Roche
Phase 3
900
Salvador, Brasília, Belo Horizonte, Curitiba, Porto Alegre, Ribeirão Preto, São José do Rio Preto, São Paulo
2025-11-24
Recruiting
Eli Lilly and Company
Phase 2
400
Brasília, Campinas, Marília, Rio de Janeiro, São Bernardo do Campo, São Paulo, Valinhos
2025-11-24
Active, closed
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT07087054Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum
Crinetics Pharmaceuticals Inc.
Phase 3
141
São Paulo, Barretos, Criciúma, Fortaleza, Porto Alegre, Rio de Janeiro
2025-11-19
Recruiting
Bayer
Phase 3
111
Uberlândia, Curitiba, Porto Alegre, Marília, Salvador, São Paulo
2025-11-19
Active, closed
Hoffmann-La Roche
Phase 2
193
Salvador, Curitiba, Porto Alegre, Joinville, São Paulo
2025-11-13
Recruiting
AstraZeneca
Phase 3
420
Porto Alegre, São Paulo
2025-11-11
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Fortaleza, Rio de Janeiro, Porto Alegre, Joinville, Santo André, São Paulo
2025-11-11
Recruiting
AstraZeneca
Phase 2
435
Blumenau, Campinas, Curitiba, Porto Alegre, Salvador, São José dos Campos, São Paulo
2025-11-06
By invitation
University of Sao Paulo General Hospital
Not applicable
24
São Paulo
2025-11-03
Not yet open
Hospital Israelita Albert Einstein
Phase 2
42
São Paulo
2025-11-01
Not yet open
University of Sao Paulo General Hospital
Observational
1,000
São Paulo
2025-11-01
Not yet open
Information Sources in Pulmonary Hypertension
NCT07207525Pulmonary Arterial Hypertension (PAH)
University of Sao Paulo General Hospital
Observational
100
São Paulo
2025-11
Recruiting
D'Or Institute for Research and Education
Phase 2
40
Brasília, Curitiba, Rio de Janeiro, Salvador, São Paulo
2025-10-31
Recruiting
AstraZeneca
Phase 3
400
Porto Alegre, Salvador, São Paulo
2025-10-31
Recruiting
BioNTech SE
Phase 3
558
Brasília, Curitiba, Goiânia, Pelotas, Porto Alegre, São Paulo, Vitória
2025-10-30
Recruiting
Novartis Pharmaceuticals
Phase 3
12
Brasília, Natal, Porto Alegre, Santo André, São Paulo
2025-10-28
Recruiting
Hoffmann-La Roche
Phase 3
600
Fortaleza, Curitiba, Natal, Porto Alegre, Barretos, São Paulo
2025-10-24
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Vitória, Salvador, Belo Horizonte, Natal, Santa Cruz do Sul, Barretos, Rio de Janeiro, São Paulo
2025-10-23
Recruiting
University of Nove de Julho
Not applicable
84
São Paulo
2025-10-16
Recruiting
Vega Therapeutics, Inc
Phase 3
60
Recife, Rio de Janeiro, Campinas, São Paulo
2025-10-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Fortaleza, Vitória, Recife, Porto Alegre, Florianópolis, Ribeirão Preto, Santo André, São Paulo
2025-10-08
Recruiting
Bristol-Myers Squibb
Observational
223
Porto Alegre, São Paulo
2025-10-08
Recruiting
Genentech, Inc.
Phase 1/2
285
Recife, Ijuí, Porto Alegre, São Paulo
2025-10-07
Recruiting
AC Camargo Cancer Center
Not applicable
84
São Paulo
2025-10-06
Recruiting
Federal University of São Paulo
Not applicable
200
São Paulo
2025-10-06
Recruiting
Hoffmann-La Roche
Phase 2
12
Brasília, Curitiba, Porto Alegre, São Paulo
2025-10-06
Recruiting
Pfizer
Phase 2/3
982
Vitória, Belo Horizonte, Natal, Porto Alegre, São Paulo
2025-10-03
Recruiting
AstraZeneca
Phase 1/2
283
Barretos, Porto Alegre, São Paulo
2025-10-01
Not yet open
Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor
NCT07078357Rheumatic Heart Disease, Rheumatic Heart Disease in Children, Vaccine Adverse Reaction, Rheumatic Diseases
University of Sao Paulo General Hospital
Phase 1/2
60
São Paulo
2025-10-01
Not yet open
NVMedTech
Phase 1
20
Fortaleza, Rio de Janeiro, São Paulo
2025-10
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Salvador, Porto Alegre, Rio de Janeiro, São Paulo
2025-09-30
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Belo Horizonte, Goiânia, Porto Alegre, Recife, Salvador, São Paulo
2025-09-30
Recruiting
Pfizer
Phase 3
680
Passo Fundo, Blumenau, São Paulo
2025-09-29
Recruiting
Pfizer
Phase 3
1,000
Fortaleza, Curitiba, Ijuí, Porto Alegre, Santo André, São José do Rio Preto, São Paulo, Sorocaba
2025-09-28
Active, closed
Merck Sharp & Dohme LLC
Phase 2
315
Juiz de Fora, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
2025-09-26
Recruiting
Sanofi
Phase 4
218
Feira de Santana, Salvador, Goiânia, Porto Alegre, São Paulo
2025-09-22
Active, closed
Bristol-Myers Squibb
Phase 2
76
Brasília, Belo Horizonte, Porto Alegre, Barretos, São Paulo
2025-09-19
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
Recife, Salvador, São Paulo
2025-09-19
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Belo Horizonte, Porto Alegre, São Paulo
2025-09-17
Recruiting
Sanofi
Phase 3
942
Goiânia, Belo Horizonte, Porto Alegre, São Bernardo do Campo, São Paulo
2025-09-17
Recruiting
Sanofi
Phase 3
942
Brasília, Curitiba, Natal, Porto Alegre, São José do Rio Preto, São José dos Campos, Rio de Janeiro, São Paulo
2025-09-16
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Salvador, Rio de Janeiro, Pôrto Alegre, Ribeirão Preto, Brasília, Porto Alegre, São Paulo
2025-09-16
Recruiting
Vaginal Mesh Surgery Versus Robotic-assisted Abdominal Mesh Surgery in the Treatment of Apical Prolapse - Prospective Randomized Non-inferiority Study
NCT07359755Pelvic Organ Prolapse (POP), Pelvic Organ Prolapse Vaginal Surgery, Mesh Reinforcement, Vaginal Apex/Uterine Prolapse
University of Sao Paulo General Hospital
Not applicable
86
São Paulo
2025-09-15
Recruiting
Butantan Institute
Phase 1/2
700
Belo Horizonte, Recife, São José do Rio Preto, Serrana, São Paulo
2025-09-10
Recruiting
Janssen Research & Development, LLC
Phase 3
220
Natal, Presidente Prudente, São José do Rio Preto, São Paulo
2025-09-10
Recruiting
Hoffmann-La Roche
Phase 2
120
Goiânia, Recife, Porto Alegre, São Paulo
2025-09-09
Recruiting
University of Nove de Julho
Not applicable
42
São Paulo
2025-09-06
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
125
Salvador, Porto Alegre, São Paulo
2025-09-04
Recruiting
BeOne Medicines
Phase 3
500
Araçatuba, Belo Horizonte, Curitiba, Goiânia, Rio de Janeiro, Salvador, São Paulo
2025-09-04
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Florianópolis, Joinville, Natal, Porto Alegre, São Paulo
2025-09-02
Not yet open
Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity (MARES3)
NCT07134855Chronic Obstructive Pulmonary Disease (COPD), Asthma, Preserved Ratio Impaired Spirometry (PRISM)
University College, London
Observational
473
São Carlos, São Paulo
2025-09-01
Recruiting
Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
NCT07120789Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Hypertension
University of Sao Paulo General Hospital
Not applicable
215
São Paulo
2025-09-01
Recruiting
Letrozole Extended vs Traditional Therapy for Ovulation Induction in Women With PCOS (PROLEx-PCOS)
NCT07159880PCOS (Polycystic Ovary Syndrome), Infertility, Anovulation
GABRIEL MONTEIRO PINHEIRO
Not applicable
20
São Paulo
2025-09-01
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Campinas, São Paulo
2025-08-28
Recruiting
Basilea Pharmaceutica
Phase 3
234
Curitiba, São Paulo, Porto Alegre
2025-08-26
Recruiting
Pfizer
Phase 3
6,000
Salvador, Curitiba, Natal, Porto Alegre, Santa Maria, São José do Rio Preto, São Paulo
2025-08-25
Recruiting
Climb Bio, Inc.
Phase 2
45
Belo Horizonte, Minas Gerais, Pernambuco, Porto Alegre, São Paulo
2025-08-25
Recruiting
University of Minnesota
Observational
1,500
São Paulo
2025-08-25
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
DrugsEmpasiprubart·IVIG
argenx
Phase 3
218
São Paulo, Salvador
2025-08-22
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
153
Fortaleza, São Paulo
2025-08-21
Recruiting
The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
NCT07013149Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
University of Sao Paulo General Hospital
Observational
183
São Paulo
2025-08-20
Active, closed
Amgen
Phase 3
350
Belo Horizonte, Natal, Porto Alegre, São José do Rio Preto, São Paulo
2025-08-18
Recruiting
Sanofi
Phase 3
90
Vitória, Goiânia, São Paulo
2025-08-18
Not yet open
Hospital Israelita Albert Einstein
Not applicable
130
São Paulo
2025-08-15
Recruiting
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
NCT07019922Epileptic Encephalopathy, SCN2A Encephalopathy
Praxis Precision Medicines
Phase 3
40
Porto Alegre, São Paulo
2025-08-13
Recruiting
Sanofi
Phase 3
192
Salvador, Goiânia, São José do Rio Preto, São Paulo
2025-08-12
Recruiting
GlaxoSmithKline
Phase 3
420
Florianópolis, Barretos, CuritibaPR, Porto Alegre, Rio de Janeiro, São Paulo
2025-08-11
Recruiting
Silimed Industria de Implantes Ltda
Observational
152
Rio de Janeiro, Santo André, São Paulo
2025-08-06
Recruiting
Sanofi
Phase 3
723
Fortaleza, Curitiba, Marília, Rio de Janeiro, São Paulo
2025-08-06
Recruiting
Pfizer
Phase 3
400
Vitória, Londrina, Ijuí, Porto Alegre, Lages, São Caetano do Sul, São Paulo
2025-08-05
Recruiting
University of Nove de Julho
Not applicable
90
São Paulo
2025-08-01
Active, closed
Psychotherapy Group for Parents of Children With LCA
NCT07026565Leber Congenital Amaurosis (LCA)
Instituto de Genética Ocular
Not applicable
40
São Paulo
2025-08-01
Not yet open
Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity
NCT07093021Chronic Obstructive Pulmonary Disease (COPD), Asthma, Preserved Ratio Impaired Spirometry
University College, London
Observational
1,000
São Carlos, São Paulo
2025-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
4,390
Manaus, Salvador, Belo Horizonte, Nova Iguaçu, São Paulo, Rio de Janeiro
2025-07-31
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
298
Natal, Porto Alegre, São Paulo
2025-07-30
Recruiting
AbbVie
Phase 3
120
Juiz de Fora, Curitiba, São Paulo
2025-07-28
Recruiting
Celgene
Phase 3
400
Vitória, Niterói, Porto Alegre, São Paulo, Rio de Janeiro
2025-07-28
Recruiting
Left Bundle Branch Area Pacing (LBBAP) PMCF Study
NCT07217392Bradycardia, Right Ventricular Pacing, Heart Failure, Atrial Fibrillation (AF)
Abbott Medical Devices
Not applicable
200
Rio de Janeiro, São Paulo
2025-07-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Recife, Natal, Porto Alegre, Santa Cruz do Sul, Lages, São Paulo
2025-07-21
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Porto Alegre, São Paulo
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
586
Fortaleza, Maringá, Rio de Janeiro, São Paulo
2025-07-21
Recruiting
Daiichi Sankyo
Phase 2
130
Curitiba, Minas Gerai, Porto Alegre, Rio de Janeiro, San Jose Rio Preto, São Paulo
2025-07-18
Recruiting
V-IMMUNE® for Immune Thrombocytopenia
NCT06962631Immune Thrombocytopenia (ITP)
DrugImmunoglobulin
On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.
Phase 3
31
Recife, São Paulo
2025-07-18
Recruiting
Daiichi Sankyo
Phase 1
76
Asa Sul, Goiás, Porto Alegre, Santo André, São Paulo
2025-07-17
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Barretos, Belo Horizonte, Porto Alegre, São José do Rio Preto, São Paulo
2025-07-17
Recruiting
Pfizer
Phase 3
300
Belo Horizonte, Curitiba, Bairro Santa Cecília, Campinas, Jaú, Rio de Janeiro, São Paulo
2025-07-14
Recruiting
Bristol-Myers Squibb
Phase 3
586
Brasília, Curitiba, Aracaju, São Paulo
2025-07-14
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
89
São Paulo
2025-07-14
Not yet open
Low Dose Radiotherapy for Heart Failure
NCT07037524Heart Failure - NYHA II - IV
Hospital do Coracao
Phase 1/2
10
São Paulo
2025-07-14
Recruiting
Bristol-Myers Squibb
Phase 3
426
Brasília, Curitiba, Porto Alegre, Campinas, Rio de Janeiro, São Paulo
2025-07-10
Active, closed
Praxis Precision Medicines
Phase 3
160
Rio Grande, Paraná, Rio de Janeiro, São Paulo
2025-07-09
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA
Artiva Biotherapeutics, Inc.
Phase 2
90
Brasília, Cuiabá, Porto Alegre, Rio Grande, São Paulo
2025-07-09
Recruiting
PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
NCT06998329Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Arterial Hypertension
University of Sao Paulo General Hospital
Observational
139
São Paulo
2025-07-07
Active, closed
Novartis Pharmaceuticals
Phase 2
168
Fortaleza, Porto Alegre, São Paulo
2025-07-07
Not yet open
A Multifaceted Intervention on Reducing Immunization Errors
NCT06745635Vaccines, Vaccines Adverse Reaction, Vaccine Practice
Hospital Israelita Albert Einstein
Not applicable
72
São Paulo
2025-07-03
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Natal, Porto Alegre, Bragança Paulista, Ribeirão Preto, São José do Rio Preto, São Paulo
2025-07-03
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Curitiba, Maringá, Porto Alegre, Joinville, São Bernardo do Campo, São Paulo
2025-07-02
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Belo Horizonte, Campinas, Porto Alegre, Recife, Ribeirão Preto, Rio de Janeiro, Salvador, São Paulo
2025-07-02
Recruiting
Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.
NCT07099859Heart Valve Diseases, Left Ventricle Remodeling, Aortic Regurgitation Disease, Heart Failure Congestive
DrugLosartan
Vitor Emer Egypto Rosa
Phase 4
60
São Paulo
2025-07-01
Active, closed
Autologous Fat Grafting in Upper Limb Burns Scars
NCT07186322Autologous Fat Grafting, Burn, Corticosteroid Injection
Federal University of São Paulo
Not applicable
40
São Paulo
2025-07-01
Recruiting
Novartis Pharmaceuticals
Phase 3
940
São Paulo
2025-07-01
Recruiting
Mitigating Chronic Respiratory Disease Through the Lens of Multi-Morbidity
NCT07050823Chronic Obstructive Pulmonary Disease (COPD), Asthma, Preserved Ratio Impaired Spirometry
University College, London
Observational
859
São Carlos, São Paulo
2025-07-01
Not yet open
Dose Optimization and Efficacy Assessment of a Fluoropyrimidine Antidote
NCT07032142Cancer, Toxicity Due to Chemotherapy
D'Or Institute for Research and Education
Phase 1/2
66
Salvador, Brasília, Curitiba, Rio de Janeiro, São Paulo
2025-07
Not yet open
Hospital Israelita Albert Einstein
Observational
30
São Paulo
2025-06-25
Recruiting
Evaluation by Clinical and Hand Ultrasound in Carpal Tunnel Syndrome
NCT07134361Carpal Tunnel Syndrome (CTS), Carpal Tunnel Surgery
University of Sao Paulo General Hospital
Observational
106
São Paulo
2025-06-25
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Fortaleza, Porto Alegre, Joinville, São Paulo
2025-06-23
Not yet open
ASPIRE (Aub-haS2 Plus bIomaRkErs)
NCT05742282Perioperative Medicine
Hospital Samaritano Paulista
Observational
2,500
São Paulo
2025-06-21
Active, closed
Autologous Serum Obtained by a Closed-Circuit Collection Device
NCT07014059GVHD, Meibomian Gland Dysfunction (Disorder), Stevens-Johnson Syndrome, Limbal Keratoconjunctivitis
GIANCARLO FATOBENE
Phase 2
16
São Paulo
2025-06-20
Recruiting
Pfizer
Phase 2
620
Brasília, Belo Horizonte, Porto Alegre, Campinas, Ribeirão Preto, São José do Rio Preto, Botucatu, São Paulo
2025-06-19
Active, closed
Cephea South America Feasibility Study
NCT07244939Mitral Regurgitation, Mitral Stenosis
Abbott Medical Devices
Not applicable
20
São Paulo
2025-06-17
Recruiting
GlaxoSmithKline
Phase 1/2
346
Porto Alegre, São Paulo, Teresina
2025-06-11
Recruiting
BeOne Medicines
Phase 3
630
Belo Horizonte, Campinas, Curitiba, Niterói, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
2025-06-11
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Campinas, São Caetano do Sul, São Paulo
2025-06-10
Recruiting
BioNTech SE
Phase 3
480
Ipatinga, Passo Fundo, Porto Alegre, São José do Rio Preto, São Paulo
2025-06-10
Active, closed
Biogen
Phase 3
255
Brasília, Campinas, São Paulo
2025-06-09
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Barra Mansa, Botucatu, Brasília, Goiânia, Porto Alegre, São Bernardo do Campo, São Paulo
2025-06-09
Recruiting
Percutaneous Blockade of the Stellate Ganglion in Electrical Storm
NCT07211347Electrical Storm, Stellate Ganglion Block, Ventricular Arrhythmia
University of Sao Paulo General Hospital
Phase 4
64
São Paulo
2025-06-06
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Barretos, Brasília, Curitiba, Natal, Rio de Janeiro, São Paulo
2025-06-04
Recruiting
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
NCT06891443Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis, Sensation Disorders
DrugSepofarsen
Laboratoires Thea
Phase 3
32
Belo Horizonte, São Paulo
2025-06-04
Recruiting
University of Sao Paulo
Phase 4
150
São Paulo
2025-06-04
Recruiting
University of Sao Paulo
Not applicable
30
São Paulo
2025-06-01
Recruiting
Sedentary Behavior and Depressive Symptoms
NCT07007234Depression, Anxiety
University of Sao Paulo General Hospital
Not applicable
84
São Paulo
2025-06-01
Recruiting
Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery
NCT07268846Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
AC Camargo Cancer Center
Not applicable
164
São Paulo
2025-06-01
Not yet open
Federal University of São Paulo
Phase 4
90
São Paulo
2025-06-01
Not yet open
University of Sao Paulo General Hospital
Not applicable
246
São Paulo
2025-06-01
Not yet open
Neurolytic Block Techniques In Abdominal Visceral Cancer Pain
NCT06978673Cancer, Malignant Tumors, Abdominal Cancer, Cancer Pain, Visceral Pain
Instituto do Cancer do Estado de São Paulo
Not applicable
64
São Paulo
2025-05-30
Recruiting
Prophylactic Antibiotic Duration in Head and Neck Cancer Surgery (PROTECT-HN Trial)
NCT07851857Surgical Wound Infection, Head and Neck Neoplasms, Oral Cancer Neoplasms, Pharyngeal Neoplasms
AC Camargo Cancer Center
Phase 3
80
São Paulo
2025-05-29
Active, closed
AstraZeneca
Phase 3
3,103
Brasília, Campina Grande do Sul, Campinas, Goiânia, Porto Alegre, Rio de Janeiro, São Paulo
2025-05-28
Recruiting
Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)
NCT05477901Inflammation, HPA, CBCL, Family Relations
New York State Psychiatric Institute
Not applicable
450
São Paulo
2025-05-28
Active, closed
Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower Oils
NCT07289919Cardiovascular (CV) Risk, Atheroscleroses, Inflamation, Omega 3 Fatty Acids
University of Sao Paulo
Not applicable
15
São Paulo
2025-05-26
Recruiting
Biogen
Phase 3
180
Belo Horizonte, Porto Alegre, Ribeirão Preto, São José do Rio Preto, São Paulo
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Goiânia, Natal, Porto Alegre, São Paulo, Rio de Janeiro
2025-05-22
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Barretos, Jaú, Natal, Porto Alegre, Rio de Janeiro, Santo André, São José do Rio Preto, São Paulo
2025-05-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Belo Horizonte, Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
2025-05-13
Recruiting
Hoffmann-La Roche
Phase 3
425
Volta Redonda, Porto Alegre, Aracaju, Jaú, São José do Rio Preto, São Paulo
2025-05-12
Active, closed
Eli Lilly and Company
Phase 3
465
Brasília, Campinas, Curitiba, Goiânia, Porto Alegre, Rio de Janeiro, São Paulo
2025-05-12
Recruiting
Biogen
Phase 3
454
Belo Horizonte, Juiz de Fora, Caxias do Sul, Porto Alegre, São Paulo
2025-05-08
Recruiting
Oticon Medical
Observational
270
São Paulo
2025-05-07
Recruiting
imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce
NCT06850792Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension
University of Sao Paulo General Hospital
Not applicable
61
São Paulo
2025-05-07
Recruiting
Takeda
Phase 3
225
Curitiba, Porto Alegre, Joinville, Jaú, Santo André, São José do Rio Preto, Rio de Janeiro, São Paulo
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Barretos, Porto Alegre, Santa Maria, São Paulo, Vitória
2025-05-06
Active, closed
Mediar Therapeutics
Phase 2
168
Belo Horizonte, Curitiba, Passo Fundo, Porto Alegre, São Bernardo do Campo, São Paulo
2025-05-05
Active, closed
University of Sao Paulo
Not applicable
30
São Paulo
2025-05-05
Recruiting
University of Sao Paulo General Hospital
Not applicable
72
São Paulo
2025-05-01
Recruiting
University of Sao Paulo
Not applicable
50
São Paulo
2025-05-01
Recruiting
Pontificia Universidad Catolica de Chile
Observational
1,500
São Paulo
2025-05-01
Recruiting
University of Sao Paulo General Hospital
Observational
60
São Paulo
2025-05-01
Recruiting
Addressing Unintentional Leakage When Using Nasal CPAP - Study A
NCT06570616Continuous Positive Airway Pressure, Adverse Effect, Obstructive Sleep Apnea
University of Sao Paulo General Hospital
Not applicable
100
São Paulo
2025-04-30
Recruiting
Addressing Unintentional Leakage When Using Nasal CPAP - Study B
NCT06570629Continuous Positive Airway Pressure, Adverse Effect, Obstructive Sleep Apnea
University of Sao Paulo General Hospital
Not applicable
50
São Paulo
2025-04-30
Recruiting
Novartis Pharmaceuticals
Phase 2
130
Montes Claros, Recife, Rio de Janeiro, Porto Alegre, São Caetano do Sul, São Paulo
2025-04-28
Active, closed
Eli Lilly and Company
Phase 3
905
Curitiba, Fortaleza, Goiânia, São Paulo, Vitória
2025-04-25
Recruiting
Arrowhead Pharmaceuticals
Phase 3
288
Fortaleza, Belo Horizonte, Curitiba, Porto Alegre, Pôrto Alegre, São Paulo
2025-04-24
Recruiting
AbbVie
Phase 2
390
Salvador, Ijuí, Barretos, São José do Rio Preto, São Paulo
2025-04-24
Recruiting
University of Nove de Julho
Not applicable
50
São Paulo
2025-04-23
Recruiting
AC Camargo Cancer Center
Observational
250
São Paulo
2025-04-23
Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
NCT06512883Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
14
São Paulo
2025-04-17
Active, closed
EyeBiotech Ltd.
Phase 2/3
1,054
Aparecida de Goiânia, Assis, Belo Horizonte, Blumenau, Porto Alegre, São Paulo, Sorocaba, Vitória
2025-04-16
Active, closed
Instituto do Cancer do Estado de São Paulo
Phase 2
276
São Paulo
2025-04-10
Recruiting
Hospital do Coracao
Phase 2
60
São Paulo
2025-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Natal, Porto Alegre, Lages, São José do Rio Preto, Rio de Janeiro, São Paulo
2025-04-09
Recruiting
Gilead Sciences
Phase 3
695
Fortaleza Ceara, Ijuí, Natal, Porto Alegre, Recife Pernambuco, Santa Lúcia, Santo André, São Paulo
2025-04-04
Recruiting
University of Sao Paulo
Phase 2
60
São Paulo
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Brasília, Ribeirão Preto, São Paulo
2025-04-01
Not yet open
Federal University of São Paulo
Not applicable
288
São Paulo
2025-04
Not yet open
Predicting Outcomes Using Infra-red SEnsors, a Feasibility Study.
NCT06515080General Anesthetic Drug Adverse Reaction
Uppsala University
Observational
500
São Paulo
2025-03-31
Recruiting
AstraZeneca
Phase 3
600
Barretos, Belo Horizonte, Goiânia, Londrina, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
2025-03-27
Recruiting
Beneficência Portuguesa de São Paulo
Phase 4
55
São Paulo
2025-03-26
Recruiting
AstraZeneca
Phase 2
540
Caxias do Sul, Criciúma, Porto Alegre, Salvador, Santo André, São José do Rio Preto, São Paulo, Sorocaba
2025-03-26
By invitation
University of Nove de Julho
Not applicable
24
São Paulo
2025-03-24
Active, closed
Immutep S.A.S.
Phase 3
756
Caxias do Sul, Curitiba, Horizonte, Ijuí, Porto Alegre, São Paulo, Vitória
2025-03-21
Recruiting
Daiichi Sankyo
Phase 3
582
Belo Horizonte, Blumenau, Jaú, Natal, Porto Alegre, Santo André, São José do Rio Preto, São Paulo
2025-03-19
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Campinas, Belo Horizonte, Brasília, Curitiba, Joinville, Porto Alegre, São Paulo, Vila Clementino
2025-03-18
Recruiting
Hoffmann-La Roche
Phase 3
600
Salvador, Brasília, Curitiba, Porto Alegre, Botucatu, Campinas, São Paulo
2025-03-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Recife, Natal, Porto Alegre, Barretos, São Jose Do Rio Preto, São Paulo
2025-03-16
By invitation
D'Or Institute for Research and Education
Observational
500
Fortaleza, Salvador, Brasília, Curitiba, Recife, Rio de Janeiro, São Paulo
2025-03-14
Recruiting
Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
NCT06640283HPV-Related Carcinoma, Uterine Cervical Cancer, Anal Canal Cancer, HPV-Related Anal Squamous Cell Carcinoma
DrugPembrolizumab
Instituto do Cancer do Estado de São Paulo
Phase 2
150
São Paulo
2025-03-14
By invitation
University of Sao Paulo
Not applicable
200
São Paulo
2025-03-13
Active, closed
Celgene
Phase 3
960
Belo Horizonte, Natal, Porto Alegre, São Paulo
2025-03-13
Active, closed
Novartis Pharmaceuticals
Phase 2
126
Salvador, Barretos, São Paulo
2025-03-13
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Nova Lima, São Paulo
2025-03-12
Recruiting
University of Sao Paulo
Not applicable
200
São Paulo
2025-03-10
Active, closed
Takeda
Phase 3
601
Juiz de Fora, Uberlândia, Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
2025-03-10
Recruiting
University of Sao Paulo General Hospital
Not applicable
480
São Paulo
2025-03-10
Active, closed
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores, AMR
DrugALXN2030
Alexion Pharmaceuticals, Inc.
Phase 2
47
Botucatu, Campinas, Porto Alegre, São Paulo
2025-03-07
Active, closed
An Ophthalmic Safety Study in Patients With Breast Cancer
NCT06767462Ophthalmic Safety in Patients With Breast Cancer
AstraZeneca
Observational
160
Alfenas, Belo Horizonte, Curitiba, Lajeado, Porto Alegre, Pouso Alegre, São Paulo, Sorocaba
2025-03-05
Recruiting
GlaxoSmithKline
Phase 1/2
305
Barretos, Goiânia, Natal, Porto Alegre, São Paulo, Vitória
2025-03-04
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
8,000
Curitiba, Florianópolis, Porto Alegre, São Paulo
2025-03-01
Recruiting
AstraZeneca
Phase 3
840
Barretos, Brasília, Campo Grande, Natal, Porto Alegre, Recife, Salvador, São Paulo
2025-03-01
Recruiting
CRYoablation for Small Tumors As Local Treatment - SIX Trial
NCT06839001Breast Cancer, Breast Neoplasm
Hospital do Coracao
Phase 3
750
São Paulo
2025-03-01
Active, closed
Antimicrobial Stewardship Program Implementation in Brazilian Public Hospitals (PeGASUS)
NCT07514884Antimicrobial Stewardship Program, Resistance Bacterial
Hospital Alemão Oswaldo Cruz
Not applicable
54
São Paulo
2025-03-01
Recruiting
University of Sao Paulo
Observational
300
São Paulo
2025-03
Active, closed
Sanofi
Phase 2
84
Curitiba, São Paulo
2025-02-28
Recruiting
Novartis Pharmaceuticals
Phase 2/3
443
São Paulo
2025-02-27
Recruiting
Bristol-Myers Squibb
Phase 3
530
Fortaleza, Porto Alegre, Santa Cruz do Sul, Itajaí, Barretos, São Paulo
2025-02-25
Recruiting
An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia
NCT06712823Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 2
200
Curitiba, Porto Alegre, Botucatu, Rio de Janeiro, São Paulo
2025-02-25
Recruiting
University of Sao Paulo General Hospital
Not applicable
36
São Paulo
2025-02-25
Recruiting
Capstan Medical TMVR Study: FIH
NCT06600191Mitral Regurgitation
Capstan Medical
Not applicable
10
São Paulo
2025-02-24
By invitation
University of Nove de Julho
Not applicable
84
São Paulo
2025-02-24
Recruiting
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
NCT06435286Suspected or Known Squamous Cell Neoplasia, Prior History of Squamous Cell Dysplasia and /or Neoplasia
Baylor College of Medicine
Phase 2
200
Barretos, São Paulo
2025-02-17
Recruiting
Novo Nordisk A/S
Phase 3
510
Recife, Distrito de Barão Geraldo - Campinas, São Paulo, Ribeirão Preto, Rio de Janeiro
2025-02-17
Active, closed
Brazilian Clinical Research Institute
Phase 4
144
Feira de Santana, Belém, Teresina, Ijuí, Rio de Janeiro, São Paulo
2025-02-17
By invitation
Longboard Pharmaceuticals
Phase 3
324
Curitiba, Porto Alegre, São Paulo
2025-02-12
Active, closed
Sanofi
Phase 3
231
Ribeirão Preto, São José dos Campos, São Paulo
2025-02-12
Recruiting
Dianthus Therapeutics
Phase 3
256
Rio de Janeiro, Campinas, Belo Horizonte, Natal, Porto Alegre, Salvador, São Paulo
2025-02-10
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Salvador, Brasília, Caxias do Sul, Porto Alegre, São Paulo
2025-02-07
Recruiting
FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection
NCT07174206Heart Diseases, Atrial Fibrillation (AF), Angina, Unstable
University of Sao Paulo
Not applicable
520
São Paulo
2025-02-07
Active, closed
University of Sao Paulo
Not applicable
30
São Paulo
2025-02-03
Recruiting
Acute Effects of Isoenergetic HIIE vs. MICE on Key Parameters of Fat Mass Loss in Young Females With Overweight or Obesity
NCT06868862Overweight and Obese Adults, High Intensity Interval Exercise (HIIE)
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
Not applicable
15
São Paulo
2025-02-01
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Ribeirão Preto, Salvador, Santo André, São Paulo
2025-02-01
Recruiting
Federal University of São Paulo
Not applicable
72
São Paulo
2025-02-01
Recruiting
Hospital Israelita Albert Einstein
Observational
693
São Paulo
2025-01-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Cascavel, Curitiba, Natal, Florianópolis, Ribeirão Preto, São Carlos, SJRP, São Paulo
2025-01-27
Recruiting
Remote Mental Practice for Freezing of Gait in Parkinson's Disease
NCT06957405Parkinson Disease, Freezing of Gait
University of Sao Paulo General Hospital
Not applicable
50
São Paulo
2025-01-25
Recruiting
BeOne Medicines
Phase 1/2
258
São Paulo, Vitória
2025-01-23
Recruiting
Benedito Mauro Rossi
Observational
60
São Paulo
2025-01-21
Active, closed
Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas
NCT06872541Assessment of Platelet Aggregability in Patients Patients with Non-small Cell Lung Carcinoma
DrugClopidogrel
University of Sao Paulo
Phase 2/3
100
São Paulo
2025-01-20
Recruiting
AbbVie
Phase 2
150
Fortaleza, Curitiba, Belém, Recife, Natal, Ijuí, Florianópolis, São Paulo
2025-01-20
Recruiting
University of Nove de Julho
Not applicable
138
São Paulo
2025-01-20
Recruiting
BeOne Medicines
Phase 1
695
Barretos, Caxias do Sul, Natal, Porto Alegre, Salvador, São Paulo, Vitória
2025-01-10
Active, closed
Hospital do Coracao
Observational
273
São Paulo
2025-01-10
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Belo Horizonte, Porto Alegre, São José do Rio Preto, São Paulo
2025-01-09
Recruiting
Positive Pressure Therapy to Optimize LUNG Function After Heart Surgery
NCT06611527Postoperative Period, Physical Therapy Modalities, Continuous Positive Airway Pressure, Respiratory Function Tests
Federal University of São Paulo
Not applicable
156
São Paulo
2025-01-08
Recruiting
University of Sao Paulo
Observational
200
São Paulo
2025-01-08
Recruiting
Takeda
Phase 3
396
Curitiba, Botucatu, Jaú, Santo André, Rio de Janeiro, São Paulo
2025-01-02
Active, closed
Federal University of São Paulo
Phase 2
40
São Paulo
2025-01-01
Not yet open
University of Sao Paulo General Hospital
Not applicable
140
Indaiatuba, São Paulo
2025-01
Active, closed
Amgen
Phase 2
61
Salvador, Natal, Porto Alegre, Barretos, São José do Rio Preto, São Paulo, Rio de Janeiro
2024-12-26
Recruiting
Associação Fundo de Incentivo à Pesquisa
Not applicable
150
São Paulo
2024-12-24
Recruiting
Sanofi
Phase 2
84
Botucatu, São Paulo
2024-12-19
Recruiting
Hospital Sirio-Libanes
Phase 4
1,500
Salvador, Brasília, Campo Grande, São Paulo, Bragança Paulista, Ponta Grossa
2024-12-18
Active, closed
argenx
Phase 3
154
Ribeirão Preto, Rio de Janeiro, Salvador, São Paulo
2024-12-18
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Barretos, São Paulo
2024-12-17
Active, closed
Hoffmann-La Roche
Phase 1
75
Curitiba, São Paulo
2024-12-17
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
55
Barretos, Belo Horizonte, Curitiba, São Paulo
2024-12-16
Recruiting
GlaxoSmithKline
Phase 3
520
Salvador, Porto Alegre, Barretos, Joinville, São Paulo, Teresina, Vitória
2024-12-16
Recruiting
Glucotrack
Not applicable
10
São Paulo
2024-12-13
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Barretos, Caxias do Sul, Jaú, Porto Alegre, Salvador, São José do Rio Preto, São Paulo, Vitória
2024-12-12
Recruiting
Instituto do Coracao
Phase 3
78
São Paulo
2024-12-12
Recruiting
Basilea Pharmaceutica
Phase 3
450
Curitiba, Porto Alegre, São Paulo
2024-12-11
Active, closed
Hoffmann-La Roche
Phase 3
350
Volta Redonda, Porto Alegre, Aracaju, Jaú, São Paulo
2024-12-11
Rows per page Showing 1–500 of 1207
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Brazilian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-brazil/city/s-o-paulo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Brazil and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,237 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,207 of those studies with a site in São Paulo.

How many clinical trials are recruiting in São Paulo?

627 of the 1,207 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 74 have not yet opened recruitment, 470 are active but closed to new participants, and 36 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (São Paulo), 1,207 studies
PhaseStudiesRecruitingShare
Phase 355123845.7%
Not applicable19711816.3%
Phase 21557812.8%
Observational1389211.4%
Phase 1/264395.3%
Phase 443273.6%
Phase 2/335202.9%
Phase 123141.9%
Early Phase 1110.1%

Most active sponsors

Lead sponsors with the most studies (São Paulo)
Lead sponsorStudiesRecruiting
AstraZeneca10749
University of Sao Paulo General Hospital7448
Hoffmann-La Roche6224
Merck Sharp & Dohme LLC6236
University of Sao Paulo5731
Novartis Pharmaceuticals5123
Janssen Research & Development, LLC3619
Bristol-Myers Squibb3014
Sanofi3011
GlaxoSmithKline259
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.